Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.SyntheMed, a biomaterials company engaged in the development and commercialization of anti-adhesion products and other surgical implants, has announced senior management changes.
Subscribe to our email newsletter
The company has announced that Richard Franklin, the company’s chairman, has assumed the newly-created position of executive chairman and Gere diZerega, one of the company’s clinical advisors, has assumed the newly-created position of medical director.
In these consultancy roles, Dr Franklin will be primarily involved with strategic planning, external communications and board leadership whereas Dr diZerega will focus on clinical and regulatory strategy and product planning, the company said.
Robert Hickey, president and CEO of SyntheMed, said: “We are very fortunate that Rick and Gere have agreed to expand their involvement with our company and we look forward to benefiting from their experience and expertise.”